Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Abivax S.A. buy Snowman

Start price
€25.50
01.12.21 / 50%
Target price
€28.00
01.12.22
Performance (%)
-31.92%
End price
€17.36
20.05.22
Summary
This prediction ended on 20.05.22 with a price of €17.36. The BUY prediction by Snowman for Abivax S.A. performed very badly with a performance of -31.92%. Snowman has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Abivax S.A. - - -
iShares Core DAX® -0.683% 1.890% 15.367%
iShares Nasdaq 100 0.335% 4.631% 29.818%
iShares Nikkei 225® -1.486% -2.361% 7.668%
iShares S&P 500 -0.523% 2.324% 25.460%

According to Snowman what are the pros and cons of Abivax S.A. for the foreseeable future?

Pros
Future proof or reliable business model
Cons
Probably not worthwhile Investment
overvalued
Very low/no dividend yield expected
Little known brand
Below average Marketposition

Comments by Snowman for this prediction

In the thread Abivax S.A. diskutieren
Prediction Buy
Perf. (%) -31.92%
Target price 28.000
Change
Ends at

Buy mit Kursziel 28,0

In the thread Trading Abivax S.A.
Prediction Buy
Perf. (%) -31.92%
Target price 28.000
Change
Ends at 01.12.22

Buy beendet

Stopped prediction by Snowman for Abivax S.A.

Abivax S.A.

Start price
Target price
Perf. (%)
€30.50
28.06.21
€25.00
28.06.22
-16.39%
01.12.21

Future proof or reliable business model
Probably not worthwhile Investment
overvalued
Very low/no dividend yield expected